Is breast-conserving therapy in the genetically predisposed breast cancer patient a reasonable and appropriate option?
Eur J Cancer
.
2004 May;40(8):1105-8.
doi: 10.1016/j.ejca.2004.01.032.
Authors
B G Haffty
,
D Lannin
PMID:
15110872
DOI:
10.1016/j.ejca.2004.01.032
No abstract available
Publication types
Comment
Editorial
MeSH terms
Breast Neoplasms / genetics
Breast Neoplasms / surgery*
DNA Repair
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Humans
Mastectomy, Segmental / methods*